MYLAN 9 4 Pill - purple oval, 13mm

Pill with imprint MYLAN 9 4 is Purple, Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Mylan Pharmaceuticals Inc.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 9 4

Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4

Carbidopa and levodopa extended release 50 mg / 200 mg MYLAN 9 4 Front

Carbidopa and Levodopa Extended Release

Imprint: MYLAN 9 4
Strength: 50 mg / 200 mg
Color: Purple
Size: 13.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
Inactive Ingredients: FD&C Blue No. 2, FD&C Red No. 40, hydroxypropyl cellulose, hypromelloses, magnesium stearate
Note: Inactive ingredients may vary.